Synopsis
0
CEP/COS
0
JDMF
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.
Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
Maithri Drugs: Dedicated to your API needs.
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.
About the Company : Established in 2004, Metrochem API is one of the fastest-growing APIs, pellets & intermediates manufacturers. It has 6 dedicated manufacturing facilities for its 3 core product gro...
Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
About the Company : Biophore, founded in 2007, develops and manufactures niche and complex pharmaceutical products. With USFDA- and EU-approved API facilities, a dedicated intermediates site and an R&...
Maithri Drugs: Dedicated to your API needs.
About the Company : Maithri Drugs Pvt. Ltd. is a global supplier of Active Pharmaceutical Ingredients (APIs), serving pharmaceutical companies in 60+ countries. Its API portfolio spans antivirals, ant...
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
ABOUT THIS PAGE
89
PharmaCompass offers a list of Cenobamate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Cenobamate manufacturer or Cenobamate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Cenobamate manufacturer or Cenobamate supplier.
PharmaCompass also assists you with knowing the Cenobamate API Price utilized in the formulation of products. Cenobamate API Price is not always fixed or binding as the Cenobamate Price is obtained through a variety of data sources. The Cenobamate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Cenobamate [INN] manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cenobamate [INN], including repackagers and relabelers. The FDA regulates Cenobamate [INN] manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cenobamate [INN] API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Cenobamate [INN] manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Cenobamate [INN] supplier is an individual or a company that provides Cenobamate [INN] active pharmaceutical ingredient (API) or Cenobamate [INN] finished formulations upon request. The Cenobamate [INN] suppliers may include Cenobamate [INN] API manufacturers, exporters, distributors and traders.
click here to find a list of Cenobamate [INN] suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Cenobamate [INN] DMF (Drug Master File) is a document detailing the whole manufacturing process of Cenobamate [INN] active pharmaceutical ingredient (API) in detail. Different forms of Cenobamate [INN] DMFs exist exist since differing nations have different regulations, such as Cenobamate [INN] USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Cenobamate [INN] DMF submitted to regulatory agencies in the US is known as a USDMF. Cenobamate [INN] USDMF includes data on Cenobamate [INN]'s chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Cenobamate [INN] USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Cenobamate [INN] suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Cenobamate [INN] Drug Master File in Korea (Cenobamate [INN] KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Cenobamate [INN]. The MFDS reviews the Cenobamate [INN] KDMF as part of the drug registration process and uses the information provided in the Cenobamate [INN] KDMF to evaluate the safety and efficacy of the drug.
After submitting a Cenobamate [INN] KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Cenobamate [INN] API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Cenobamate [INN] suppliers with KDMF on PharmaCompass.
A Cenobamate [INN] written confirmation (Cenobamate [INN] WC) is an official document issued by a regulatory agency to a Cenobamate [INN] manufacturer, verifying that the manufacturing facility of a Cenobamate [INN] active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Cenobamate [INN] APIs or Cenobamate [INN] finished pharmaceutical products to another nation, regulatory agencies frequently require a Cenobamate [INN] WC (written confirmation) as part of the regulatory process.
click here to find a list of Cenobamate [INN] suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Cenobamate [INN] as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Cenobamate [INN] API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Cenobamate [INN] as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Cenobamate [INN] and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Cenobamate [INN] NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Cenobamate [INN] suppliers with NDC on PharmaCompass.
Cenobamate [INN] Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Cenobamate [INN] GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Cenobamate [INN] GMP manufacturer or Cenobamate [INN] GMP API supplier for your needs.
A Cenobamate [INN] CoA (Certificate of Analysis) is a formal document that attests to Cenobamate [INN]'s compliance with Cenobamate [INN] specifications and serves as a tool for batch-level quality control.
Cenobamate [INN] CoA mostly includes findings from lab analyses of a specific batch. For each Cenobamate [INN] CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Cenobamate [INN] may be tested according to a variety of international standards, such as European Pharmacopoeia (Cenobamate [INN] EP), Cenobamate [INN] JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Cenobamate [INN] USP).
